BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh PK, Deorukhkar AA, Venkatesulu BP, Li X, Tailor R, Bomalaski JS, Krishnan S. Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic Dysregulation. Mol Cancer Ther 2019;18:2381-93. [PMID: 31395686 DOI: 10.1158/1535-7163.MCT-18-0708] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Tian X, Zhang S, Zhou L, Seyhan AA, Hernandez Borrero L, Zhang Y, El-Deiry WS. Targeting the Integrated Stress Response in Cancer Therapy. Front Pharmacol 2021;12:747837. [PMID: 34630117 DOI: 10.3389/fphar.2021.747837] [Reference Citation Analysis]
2 Chen CL, Hsu SC, Ann DK, Yen Y, Kung HJ. Arginine Signaling and Cancer Metabolism. Cancers (Basel) 2021;13:3541. [PMID: 34298755 DOI: 10.3390/cancers13143541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pavlova NN, King B, Josselsohn RH, Violante S, Macera VL, Vardhana SA, Cross JR, Thompson CB. Translation in amino-acid-poor environments is limited by tRNAGln charging. Elife 2020;9:e62307. [PMID: 33289483 DOI: 10.7554/eLife.62307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
4 Kang BW, Chau I. Emerging agents for metastatic pancreatic cancer: spotlight on early phase clinical trials. Expert Opin Investig Drugs 2021;:1-19. [PMID: 34727804 DOI: 10.1080/13543784.2021.1995354] [Reference Citation Analysis]
5 van Gisbergen MW, Zwilling E, Dubois LJ. Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio. Front Oncol 2021;11:653621. [PMID: 34041023 DOI: 10.3389/fonc.2021.653621] [Reference Citation Analysis]
6 Chisari A, Golán I, Campisano S, Gélabert C, Moustakas A, Sancho P, Caja L. Glucose and Amino Acid Metabolic Dependencies Linked to Stemness and Metastasis in Different Aggressive Cancer Types. Front Pharmacol 2021;12:723798. [PMID: 34588983 DOI: 10.3389/fphar.2021.723798] [Reference Citation Analysis]
7 Chow JPH, Cai Y, Chow DTL, Chung SHK, Chau KC, Ng KY, Leung OM, Wong RMH, Law AWL, Leung YO, Kwok SY, Leung YC. A modified arginine-depleting enzyme NEI-01 inhibits growth of pancreatic cancer cells. PLoS One 2020;15:e0231633. [PMID: 32353864 DOI: 10.1371/journal.pone.0231633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Marullo R, Castro M, Yomtoubian S, Calvo-Vidal MN, Revuelta MV, Krumsiek J, Cho A, Morgado PC, Yang S, Medina V, Roth BM, Bonomi M, Keshari KR, Mittal V, Navigante A, Cerchietti L. The metabolic adaptation evoked by arginine enhances the effect of radiation in brain metastases. Sci Adv 2021;7:eabg1964. [PMID: 34739311 DOI: 10.1126/sciadv.abg1964] [Reference Citation Analysis]
9 Giatromanolaki A, Harris AL, Koukourakis MI. The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer. Cancer Metab 2021;9:28. [PMID: 34344457 DOI: 10.1186/s40170-021-00264-7] [Reference Citation Analysis]
10 Read GH, Bailleul J, Vlashi E, Kesarwala AH. Metabolic response to radiation therapy in cancer. Mol Carcinog 2021. [PMID: 34961986 DOI: 10.1002/mc.23379] [Reference Citation Analysis]
11 Xu R, Yang J, Ren B, Wang H, Yang G, Chen Y, You L, Zhao Y. Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies. Front Oncol 2020;10:572722. [PMID: 33117704 DOI: 10.3389/fonc.2020.572722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]